Transforming Pharmaceutical Marketing for a New Era

Founded in 2023, we at Revisto believe that pharmaceutical companies deserve a streamlined, efficient approach to launching promotional materials—one that prioritizes compliance without compromising quality or speed.

Our Story

Our mission is to optimize the release cycle, reduce cost, and eliminate compliance risk of releasing promotional materials in the pharmaceutical industry, while improving quality and consistency.

We achieve this by applying deep industry knowledge in cutting-edge technology to automate the compliance requirements and best practices for our customers.

We strive not only to uphold the highest standards of accuracy and compliance, but also to enable the generation of data-driven, personalized, and engaging content that results in positive patient outcomes.

At the heart of our offerings is our AI-driven platform that learns from regulations, industry best practices, and our customers’ historical actions. Recommendations provided by our platform significantly reduce promotional material release time, and this level of efficiency has already earned us the trust of a Top 5 pharmaceutical company.

At Revisto, we believe in transparency and understand that trust is earned through consistent performance and open communication. We are committed to delivering results for our customers and fostering relationships built on mutual respect and shared success.

Join us as we continue to innovate and shape the future of pharmaceutical marketing.

Save over $15m annually with Revisto

Request a demo today to discover how you can streamline your content creation process

Request a Demo

Leadership Team

Ferry Tamtoro

CEO & Co-founder

Ferry leads Revisto with an extensive background spanning more than two decades in healthcare technology, with a focus on the pharmaceutical and medical device sectors. His seasoned leadership and successful track record in deploying software solutions have equipped him with a deep comprehension of the criticality of building software solutions that complies to global regulatory frameworks, as well as security and data privacy standards.

Prior to Revisto, Ferry co-founded BrightInsight, which provides a leading global platform for biopharma and medtech regulated digital health solutions. With a wealth of experience in both startup environments and corporate innovation, Ferry is committed to fostering an environment of agility in product development and a collaborative spirit in partnership with Revisto’s customers in the regulated pharmaceutical industries.

Jaya Plmanabhan

CDO & Co-founder

With over 20+ years of experience in the life sciences, biotech, healthcare, and technology sectors, Jaya is a data-driven leader who leverages machine learning, artificial intelligence, data science and data engineering to create innovative solutions for complex problems.

Jaya has a proven track record of architecting, designing, and building scalable, secure, and robust data platforms and applications for various domains, including drug discovery, clinical trial recruitment, patient engagement, and pharmacy benefit management.

As the Chief Data Officer and Co-Founder of Revisto, Jaya partners with pharmaceutical companies to streamline key processes, enhance quality, and drive faster releases of their innovative products to the market.

Optimize your MLR workflow with Revisto

Request a Demo